Toxic epidermolysis after diclofenac

Oral roflumilast is a phosphodiesterase-4 inhibitor approved for the prevention of exacerbations of chronic obstructive pulmonary disease and chronic bronchitis. In dermatology, topical roflumilast is authorized by the US Food and Drug Administration for the […]

Background Several studies support the hypothesis that scabies is on the rise in Spain. There are also concerns about the possible development of resistance to treatment and an increase in atypical presentations. The aims of […]

Although invasive techniques such as scalp biopsies and non-invasive techniques such as trichoscopy are commonly used for the diagnosis and management of alopecia, the latter does not always provide enough information on the state of […]